34
Participants
Start Date
May 7, 2021
Primary Completion Date
July 8, 2021
Study Completion Date
December 31, 2021
single 1-hour IV infusion of 0.8 mg/kg recAP
Intravenous infusion
single 1-hour IV infusion of 1.6 mg/kg recAP
Intravenous infusion
single 1-hour IV infusion of 3.2 mg/kg recAP
Intravenous infusion
1-hour infusions of 1.6 mg/kg recAP on Days 1, 2 and 3
Intravenous infusion
Placebo
Intravenous infusion
P-One Clinic, Keikokai Medical Corporation, Tokyo
Lead Sponsor
AM-Pharma
INDUSTRY